RACHEL REED: Open Payments
NPI 1417145293 · MOREHEAD CITY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 29 payments from 19 companies in 2025. Trend: 2023 $350 · 2024 $525 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $100 |
| ABBVIE INC. | 3 | $57 |
| Amgen Inc. | 3 | $42 |
| Novo Nordisk Inc | 2 | $38 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Lundbeck LLC | 1 | $24 |
| Boston Scientific Corporation | 1 | $24 |
| Abbott Laboratories | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: AIRSUPRA, REXULTI, OTEZLA, VRAYLAR, TRELEGY ELLIPTA, WaveWriter Alpha Prime 16, FREESTYLE LIBRE 3, Ozempic.
Industry payments across NC — which companies pay providers there.
